It indicates that aliskiren may stimulate glucose utilization and increase insulin sensitivity in skeletal muscle, contributing to the improvement of systemic insulin resistance and reduction in serum glucose levels in HFD-fed mice. This evidence concerns the gene INS and Insulin resistance.